TrialThe Journal of clinical investigation2020

COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain.

Massimiliano Secchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.